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Abstract – Highly pathogenic avian inﬂuenza (HPAI) viruses of the H5 and H7 subtype pose a major
public health threat due to their capacity to cross the species barrier and infect mammals, for example dogs,
cats and humans. In the present study we tested the capacity of selected H7 and H5 HPAI viruses to infect
and to be transmitted from infected BALB/c mice to contact sentinels. Previous experiments have shown
that viruses belonging to both H5 and H7 subtypes replicate in the respiratory tract and central nervous
system of experimentally infected mice. In this study we show that selected H7N1 and H5N1 HPAI viruses
can be transmitted from mouse-to-mouse by direct contact, and that in experimentally infected animals they
exhibit a different pattern of replication and transmission. Our results can be considered as a starting point
for transmission experiments involving other inﬂuenza A viruses with a 2-3 receptor afﬁnity in order to
better understand the viral factors inﬂuencing transmissibility of these viruses in selected mammalian
species.
highly pathogenic avian inﬂuenza virus / mouse / transmission / H7 / H5
1. INTRODUCTION
During April 2009, cases of acute respiratory
disease in humans, caused by inﬂuenza A pan-
demic H1N1 in Mexico, were reported [9].
Since that, the virus continues to spread and
is causing the ﬁrst inﬂuenza pandemic since
1968. The emergence of this novel H1N1 inﬂu-
enza virus highlighted once more the zoonotic
potential of inﬂuenza A viruses and the contin-
uous threat posed by the circulation of these
viruses in the animal reservoir.
Inﬂuenza A viruses circulate in wild aquatic
birds, their natural reservoir [8, 16, 37], but they
are able also to cross the species barrier and
infectavarietyofhosts,includinghumans.Most
inﬂuenza viruses that infect wild or domestic
birds cause no illness and death and are charac-
terized as being low pathogenic avian inﬂuenza
(LPAI) viruses. However, viruses within the
H5andH7subtypeshavethecapacitytoacquire
genetic properties that confer high virulence
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domestic poultry and are therefore characterized
as highly pathogenic avian inﬂuenza viruses
(HPAI).
Recently, some HPAI viruses of H5 and H7
subtype, which have caused a high mortality
rates in chickens, have also been associated
with mild to severe human infections [2, 7].
The increase in isolation of the H5 and H7
avian inﬂuenza viruses from poultry outbreaks
and human patients requires a better under-
standing of the pathobiology of these viruses
for the mammalian host. Interestingly, severe
natural infections caused by H5N1 HPAI
viruses have been reported in non-avian spe-
cies, such as feline [18, 19, 34], canine [10],
mustelids, and lagomorphs [39]. Therefore,
molecular events governing transmission of
HPAI viruses in non-avian susceptible species
should be properly investigated.
I nt h ep r e s e n ts t u d yw eu s e dB A L B / cm i c e
to evaluate the pathogenicity and the transmis-
sion potential of HPAI viruses and to investi-
gate the use of this species to study viral
factors affecting transmission in non-avian spe-
cies. The mouse model has been extensively
used to identify virulence determinants of inﬂu-
enza viruses as recently reviewed by Barnard
et al. [1]. In contrast, the potential use of the
mouse as a model for inﬂuenza transmission
has been neglected. In fact, transmission of
mouse-adapted human inﬂuenza viruses
between mice was described for the ﬁrst time
about 40 years ago [27]. The reason for this is
mainly related to the fact that most human inﬂu-
enza viruses require prior adaptation in mice
before they will result in a productive infection
[12] and this is most likely due to the predom-
inance of a 2-3 versus a 2 - 6s i a l i ca c i d( S A )
receptors (the latter receptors preferred by
human inﬂuenza viruses) present in murine
respiratory tissues [15, 23]. Alternative and
probably more appropriate animal models, such
as the ferret and the guinea pig, have been
therefore tested and developed for studying
the pathogenicity and transmission of human
inﬂuenza viruses as recently reviewed by Belser
et al. [2]. However, the use of ferret and guinea
pig for studying the pathogenicity and transmis-
sion in non-avian species susceptible to
inﬂuenza viruses exhibiting a 2-3 SA receptor
binding afﬁnity remains questionable.
BALB/c mice exhibit mainly a 2-3 linked
SA receptors [15, 23, 30], which are receptors
preferred by avian, equine and sea mammal
inﬂuenza viruses. At present, data on the trans-
missibility of inﬂuenza viruses exhibiting pref-
erential binding to these receptors are limited
and mainly conﬁned to avian viruses in avian
species with the exception of a recent publica-
tion [38] describing the transmission of previ-
ously mice-adapted H9N2 AI viruses to
contact mice.
More recently, the presence and distribution
of human inﬂuenza virus receptors (a 2-6 SA
receptors) in mice has also been revisited and
preliminary data indicate the presence of both
a 2-3 and a 2-6 SA receptors in the respiratory
t r a c to fB A L B / cm i c e[ 24]. Consequently, mice
are potentially suitable for studying inﬂuenza
virus infection, transmission and reassortment
in non-avian species.
The mouse is still considered an important
in vivo-model, especially because breeding of
this species is cheap, there is an extensive
knowledge of their immune system and many
immunological reagents are available for this
species [3, 36].
Furthermore, experiments can be applied
more easily on a larger number of animals,
often a key factor for transmissibility studies
and subsequent statistical analysis [36].
In this study we aim at establishing whether
BALB/c mice are suitable for transmission
experiments using inﬂuenza viruses exhibiting
preferential a 2-3 SA receptor binding afﬁnity
and capable of causing infection in non-avian
species, namely HPAI viruses of the H7N1
and H5N1 subtypes.
2. MATERIALS AND METHODS
2.1. Viruses used in this study
Two HPAI H7N1, namely A/Ostrich/Italy/2332/
2000 (Os/2332) and A/Ostrich/Italy/984/2000 (Os/
984), both isolated from ostriches during the Italian
epidemic of 1999–2000, and two HPAI H5N1
belonging to clade 2.2, namely A/Turkey/Turkey/1/
2005 (Tk/05) and A/Mallard/Italy/835/2006 (Mal/
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respectively, were used in the present study. These
viruses were chosen according to the presence or
absence of the amino acid Lys in position 627PB2,
which is known to play an important part in viral
replication and pathogenicity in mice [22, 28]. No
other known residues related to pathogenicity in mice
were detected from the amino acid sequence compar-
ison (Tab. I). None of the viruses used in this study
possesses the amino acid asparagine in position 701
of PB2 (701 N), which is considered, together with
PB2 627 K, as a determinant for mammalian inter-
host transmission in mammals [32].
All viruses were propagated in the allantoic cavity
of 9–11 day-old embryonated-speciﬁc-pathogen-free
(SPF) eggs and were titrated to determine the dose
required to infect 50% of eggs (EID50).
The50%MouseInfectiousDose(MID50)and50%
Mouse Lethal Dose (LD50) were calculated according
to Katz et al. [17], and are reported in Table II.
Brieﬂy, 4–6 week-old female BALB/c mice
(Charles River Laboratories s.r.l., Calco, Lecco,
Italia) were intranasally infected with 50 lLo f
10-fold serial dilutions of infectious virus (8 animals
per dilution). Three days after infection, 3 mice from
each group were sacriﬁced and lungs were collected.
The remaining 5 mice in each group were monitored
daily for clinical signs and mortality was recorded up
to 15 days post-infection to determine LD50 values
(Tab. II).
MID50 and LD50 values were calculated by the
Reed and Muench formula [25].
All experiments using live H7N1 and H5N1
HPAI viruses were performed in separate isolators
under bio safety level 3 (BSL3) containment.
2.2. Nasal shedding experiment
Twelve female BALB/c mice of 4–6 weeks of age
were infected with 10 LD50 of each virus to evaluate
nasal shedding. On days 3, 5, 7 and 9 post infection
(p.i.),3micefromeachgroupweresacriﬁcedandnasal
washes were performed using 300 lL of sterile PBS.
Nasal washes were tested by quantitative
Table I. Amino acid sequence comparisons of H5N1(A) and H7N1(B) viruses used in this study.
Gene Amino acid
sequence similarity (%)
No. of different
amino acids
Differing amino
acid positions
(A) Tk/05 and Mal/835
PB2 99.7 2 344, 627
PB1 99.9 1 213
PB1-F2 98.9 1 23
PA 99.6 3 70, 184, 547
HA 99.6 2 145, 325
NP 99.8 1 313
NA 99.1 4 34, 319, 320, 414
M1 100 0 –
M2 98.9 1 10
NS1 100 0
NS2 99.1 1 26
(B) Os/2332 and Os/984
PB2 99.6 3 286, 591, 627
PB1 99.6 3 598, 614, 742
PB1-F2 100 0 –
PA 100 0 –
HA 99.5 3 77, 252, 264
NP 99.6 2 104, 450
NA 100 0 –
M1 99.2 2 134, 211
M2 100 0 –
NS1 99.6 1 59
NS2 100 0 –
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2.5.3) to evaluate the amount of virus shed and pro-
cessedforvirusisolationasdescribedinSection2.5.1.
2.3. Transmission experiment
Four to six-week old female BALB/c mice were
divided intotwo different groups of 10 each. Ten mice
(group G1) were infected intranasally with 50 lLo fa
suspension containing 10 LD50 of each virus. Twenty-
four hours p.i. the infected animals were moved into a
clean cage. This cage already hosted 10 sentinel mice
( g r o u pG 2 ) .A l lm i c ew e r eo b s e r v e dt w i c ead a yf o r
clinical signs and were weighed every two days. Ten
uninfected animals were used as negative controls
a n dh o u s e di nas e p a r a t ec a g e .
2.4. Sampling procedures
Lung and brain were collected from dead G1
H7N1 mice, as no evidence of viral replication has
previously been detected in other organs using the
same experimental conditions [26]. In both H5N1
G1 groups, lung, brain, spleen, kidney, intestinal con-
tent were collected. From all dead sentinels (G2)
brain, lung, spleen, liver, kidney and intestinal con-
tent were collected. In case of no mortality among
infected animals and sentinels, two apparently
healthy mice were randomly sacriﬁced. Mice show-
ing severe signs of disease were also sacriﬁced for
ethical reasons. For each infected or sentinel animal
euthanized, a negative control mouse was also
sacriﬁced.
2.5. Laboratory tests
2.5.1. Virological assay
Tissues samples (approximately 0.3 g) and nasal
washes (approximately 300 lL) were processed by
virus isolation (VI). Tissue samples were homoge-
nized in 3 mL of phosphate-buffered saline
(0.05 M, pH 7.0–7.4) with antibiotics (penicillin:
10 000 IU/mL, streptomycin: 10 mg/mL, nystatin:
5 000 UI/mL, gentamycin sulphate: 250 lg/mL)
a n dc l a r i ﬁ e db yc e n t r i f u g a tion. The undiluted super-
natants were inoculated in 9–11 day old embryonated
SPF eggs according to EU guidelines [6].
2.5.2. Serological assay
Sera were collected from all surviving mice on
day 30 post-contact (p.c.).
Serum samples were tested by an anti-nucleopro-
tein (NP) in-house indirect ELISA, hemagglutination
inhibition assay (HI), and Western blotting using
standard procedures [11].
2.5.3. RRT-PCR analysis
Samples for molecular analysis were homoge-
nized in 0.5 mL of phosphate-buffered saline; total
RNA was extracted with a commercial kit (Rneasy
Mini kit, Qiagen, Milano, Italy) and analysed by
quantitative RRT-PCR (qRRT-PCR) using PCR
reagents (QuantiTect Multiplex RT-PCR kit, Qiagen)
in a one-step protocol.
RRT-PCR analysis were performed for all the tis-
sue sample using an inﬂuenza virus primer set [31]
speciﬁc for the M gene (M +25, M 124;
300 nM) and hydrolysis probe (M +64; 100 nM).
T h eq R R T - P C Rr e a c t i o nw a sp e r f o r m e dw i t ht h e
following protocol: 20 min at 50  C and 15 min at
95  Cf o l l o w e db y4 0c y c l e sa t9 4 C for 45 s and
60  C for 45 s. Target RNA transcripts were obtained
in vitro (Mega Short Script 7, high yield transcription
kit, Ambion, Monza, Italy), quantiﬁed by spectropho-
tometer and used to develop a standard calibration
curve for viral RNA quantiﬁcation.
Table II. EID50,L D 50 and MID50 values of AI viruses used in this study.
Virus Pathotype Strain EID50
a LD50
b MID50
c
H7N1 HPAI A/Ostrich/Italy/2332/2000 (Os/2332) 10
6.24 10
2.75 10
2
H7N1 HPAI A/Ostrich/Italy/984/2000 (Os/984) 10
6.15 10
4.75 10
3.3
H5N1 HPAI A/Turkey/Turkey/1/2005 (Tk/05) 10
7.7 10
3.4 10
2.2
H5N1 HPAI A/Mallard//Italy/835/2006 (Mal/835) 10
6.83 >1 0
6.83 >1 0
6.83
a EID50: mean egg infectious dose.
b LD50: mean mouse lethal dose.
c MID50: mean mouse infectious dose.
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The Open Reading Frames (ORF) of the original
strains and of post-infection isolates were fully
sequenced essentially as previously described [14].
DNA sequencing was performed using a 3130xl
Genetic Analyzer and BigDye Terminator Mix v3.1
(Applied Biosystems, Monza, Italy).
All the sequences of the original strains were
deposited in GenBank: Os/2332 (accession numbers
from DQ991309 to DQ 991316); Os/984 (accession
numbers from DQ991333 to DQ991339 and EF
376184); TK/05 (accession numbers from
EF619980.1 to EF619973.1), Mal/835 (accession
numbers from CY016802.1 to CY016795.1).
2.6. Statistical analysis
A non parametric test was applied for the statisti-
cal analysis. The Pearson Chi Square test was used to
evaluate whether there was a signiﬁcant difference
between the number of positive animal within the
infected G1 groups and the sentinels G2 groups.
Cox’s regression analysis was used for the calcu-
lation of the hazard ratio (HR) and the Kaplan Mayer
model was applied to the survival analysis.
3. RESULTS
3.1. Pathogenicity of H7 and H5 viruses in mice
As described in the previous sections,
BALB-c mice of 4–6 weeks of age were
divided in 4 groups of 10 each (group G1)
and intranasally infected with the following
viruses: two Italian H7N1 HPAI (G1Os/2332
and G1Os/984) both isolated from an ostrich,
and two H5N1 (G1Tk/05 and G1Mal/835) both
belonging to clade 2.2.
Mice belonging to G1Os/2332 and G1Os/984
exhibited nervous and respiratory signs and all
died by days 7 and 10 p.i. respectively
(Tab. III and Fig. 1A). Viral RNAwas detected
in the brain and the lung conﬁrming previous
observations [26], with viral loads ranging from
10
8 to 10
9 viral copies/lLa n df r o m1 0
7 to 10
9
viral copies/lL for brain and lung, respectively.
A mean weight loss of 14.4% was recorded in
G1Os/2332 whereas an average weight loss of
4.7% was recorded in G1Os/984.
G1Tk/05 mice all died by days 7 and 8 p.i.
(Tab. III and Fig. 1A). However, apart from a
mild respiratory distress syndrome, severe clin-
ical signs or changes in body weight were not
evident in this group (Tab. III).
In contrast to what was observed for both
G1 H7N1 mice, in G1Tk/05 viral RNA was not
only detected in the brain (values ranging
from 10
7 to 10
9 viral copies/lL) and in the lung
(values ranging from 10
4 to 10
8 viral copies/
lL), but also in the spleen (6 subjects; values
ranging from 10
5 to 10
6 viral copies/lL), in
the kidney (3 subjects; values ranging from
10
5 to 10
6 viral copies/lL), in the intestinal
content (3 subjects; 10
7 viral copies/lL), and
in the liver (5 subjects; values ranging from
10
4 to 10
6 viral copies/lL).
None of the G1Mal/835 mice died spontane-
ously (Tab. III and Fig. 1A). On day 6 p.i., 2
mice in an apparently healthy status were eutha-
nized. Viral RNA was detected in the lung
(5.2 · 10
4 viral copies/lL) of one mouse and
in the spleen (5.09 · 10
4 viral copies/lL) of
t h es e c o n dm o u s e .O nd a y9p . i . ,4m i c ei na n
apparently healthy status were euthanized. Viral
RNA was detected in the kidney (values
ranging from 2.21 · 10
4 to 2.38 · 10
5 viral
Table III. Clinical signs, lethality and seroconversion of infected (G1) and contact (G2) mice.
Virus Infected mice (G1) Contact mice (G2)
Clinical signs Lethality Clinical signs Lethality Seroconversion
Os/2332 Nervous and respiratory 10/10 Nervous and respiratory 8/10 No*
Os/984 Nervous and respiratory 10/10 Nervous and respiratory 5/10 No
Tk/05 Respiratory 10/10 Mild respiratory 4/10 No
Mal/835 – – – – No
* No: not observed.
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from 4.71 · 10
4 to 2.09 · 10
5 viral copies/
lL) in the 4 mice. The four surviving mice were
euthanized on day 20 p.i. and the samples col-
lected yielded no positive results.
The statistical analysis revealed that the mor-
tality incidence rate was higher in G1Os/2332
mice than in the other G1 groups. Furthermore,
the ‘‘hazard ratio’’ estimation revealed that
G1Os/2332 mice had 3 fold higher probability
(haz. ratio = 3.26) of dying than G1Tk/05 mice
(both viruses harbouring a lysine in position
627 of PB2), and that this difference was statis-
tically signiﬁcant (p < 0.05). There was no sig-
niﬁcant difference between G1Tk/05,G 1 Os/984
and G1Mal/835 mice.
The Pearson Chi Square test showed that the
number ofpositiveanimals wasnot signiﬁcantly
different between G1Os/2332 and G1Os/984,
whereas the number ofpositivemicewassignif-
icantly different between G1Tk/05 and G1Mal/835
(p = 0.04). In both G1 H7N1 mice, the number
of positive animals was not statistically signiﬁ-
cantwhencomparedtoG1Tk/05,butsigniﬁcantly
different when compared to G1Mal/835.
3.2. Nasal shedding evaluation
In mice infected with Os/2332, virus shed-
ding had a peak value on day 3 p.i. (4.1 ·
10
8 viral copies/lL) and decreased by day 5
(9.9 · 10
7 viral copies/lL). A moderate
decrease was then observed by the end of the
experiment at day 9 p.i., reaching 3.6 · 10
7
viral copies/lL( Fig. 2A).
Mice infected with Os/984 showed high
viral titre on day 3 p.i. (2.26 · 10
8 viral cop-
ies/lL), a decrease on day 5 (7 · 10
7 viral cop-
ies/lL ) ,a ni n c r e a s eo nd a y7( 1 . 5· 10
8 viral
copies/lL), ﬁnally reaching 1.63 · 10
7 viral
copies/lLb yd a y9p . i .( Fig. 2A).
With the H5N1 viruses, Tk/05 reached its
peak (2 · 10
8 viral copies/lL) on day 7 p.i.
and decreased by day 9 p.i. (3.4 · 10
7 viral
copies/lL) (Fig. 2B).
Shedding for Mal/835 peaked at day 3 p.i.
(7.6 · 10
3 viral copies/lL) and rapidly
decreased. Samples collected on days 5 and 9
yielded negative results for this virus (Fig. 2B).
Viral isolation conﬁrmed the presence of via-
ble virus particles in all the samples tested posi-
tive by qRRT-PCR (data not shown).
3.3. Transmission experiment
Twenty-four hours after infection, 10 naı ¨ve
mice per group (G2Os/2332;G 2 Os/984;G 2 Tk/05;
G2Mal/835) were placed in the same cage with
inoculated animals.
Among G2Os/2332 mice, 8 out of 10 died
(Tabs. IVA andIII),and7ofthesewereanalysed.
Figure 1. (A) Kaplan-Meier survival curve of
infected mice (G1). Ten mice per group were
intranasally infected with 10 LD50 of each virus.
(B) Kaplan-Meyer survival curve of contact mice
(G2). Time of death varied from day 7 to 10 p.i. for
infected groups (A) and from day 7 to 12 p.c. for
contact groups (B). While H5N1 Mal/835 infected
and contact mice showed a 100% survival rate, all
the other groups showed mortality rates ranging to
100% to 75%. (A color version of this ﬁgure is
available online at www.vetres.org.)
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positive results by qRRT-PCR and 5 out of 7 of
these were also conﬁrmed by VI (Tab. IVA).
Among G2Os/984 mice, 2 apparently healthy
mice were sacriﬁced on day 10 p.c., according
to the experimental design. The samples
collected from only one animal yielded positive
results by qRRT-PCR (Tab. IV B). Two contact
sentinels were found dead on day 12 p.c., and
the organs collected yielded positive results by
qRRT-PCR and VI (Tab. IV B). Two other con-
tact sentinels, presenting severe clinical signs,
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Figure 2. Nasal shedding of infected mice on days 3, 5, 7 and 9 p.i. Twelve female BALB/c mice of 4–6
weeks of age were infected with 10 LD50 of each virus to evaluate nasal shedding. On days 3, 5, 7 and 9 p.i.,
3 mice from each group were sacriﬁced and nasal washes were applied. Nasal washes were tested by
quantitative Real-Time RT-PCR and viral isolation.
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collected yielded positive results by qRRT-
PCR only (Tab. IV B).
It is of note that in both H7N1 G2 groups
viral RNAwas detected exclusively in the brain
and the respiratory tract.
No seroconversion was detected by any of
the serological tests used (HI, ELISA and
Western blotting) in G2Os/984 and G2Os/2332
surviving mice (Tab. III).
Among G2Tk/05 sentinel mice, 4 out of 10
died, without evident clinical signs or changes
in body weight (Tab. III and Fig. 1B), with viral
RNA detected in multiple organs (Tab. V A).
Two out of six sentinels sacriﬁced on day
20 p.c. showed viral RNA in the brain and
t h es p l e e n( Tab. V A).
None of G2Mal/835 mice died spontaneously
(Tab. III and Fig. 1B). Viral RNA was detected
only in the trachea/lung of a sentinel sacriﬁced
Table IV. Quantitative Real-Time RT-PCR and viral isolation of H7N1 contact mice (G2).
ID number Detail Organs qRRT-PCR Copies/lL Virus isolation
(A) G2Os/2332 contact mice
1 Dead (7th p.c.) Brain + 4.34E + 07 +
Trachea and lung trachea + 9.32E + 05 +
2 Sacriﬁced* (7th p.c.) Brain  
Trachea and lung  
3 Dead (8th p.c.) Brain + 6.61E + 08 +
Trachea and lung + 1.13E + 07 
4 Sacriﬁced* (8th p.c.) Brain  
Trachea and lung  
5 Dead (8th p.c.) NA
a NA NA NA
NA NA NA NA
6 Dead (9th p.c.) Brain NA NA NA
Trachea and lung + 5.43E + 07 +
7 Dead (9th p.c.) Brain  
Trachea and lung + 4.40E + 07 
8 Dead (12th p.c.) Brain + 2.18E + 09 +
Trachea and lung + 1.35E + 07 +
9 Dead (12th p.c.) Brain + 7.15E + 07 
Trachea and lung + 3.65E + 07 
10 Dead (12th p.c.) Brain + 5.05E + 06 
Trachea and lung + 5.77E + 07 +
(B) G2Os/984 contact mice
1 Sacriﬁced
a (10th p.c.) Brain  
Lung/trachea  
2 Sacriﬁced
a (10th p.c.) Brain + 7.63E + 04 
Lung/trachea + 9.54E + 04 
3 Dead (12th p.c.) Brain + 3.90E + 09 +
Lung/trachea + 2.65E + 07 +
4 Dead (12th p.c.) Brain + 1.03E + 10 +
Lung/trachea + 1.67E + 08 +
5 Sacriﬁced* (14th p.c.) Brain + 2.62E + 04 
Lung/trachea + 3.10E + 04 
6 Sacriﬁced* (14th p.c.) Brain + 3.26E + 07 
Lung/trachea + 4.49E + 05 
* Mice euthanized for ethical reasons.
a Not analyzed. Samples found putreﬁed could not be processed.
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by virus isolation.
No seroconversion was observed in either
G2Tk/05 or G2Mal/835 surviving animals
(Tab. III).
The statistical analysis revealed that the inci-
dence rate of mortality was higher in G2Os/2332
mice than in mice of the other G2 groups.
Furthermore, the ‘‘hazard ratio’’ estimation
revealed that G2Os/2332 mice have almost 7
times more probability of dying than G2Tk/05
mice (both harbouring a lysine in position 627
of PB2), and this difference was statistically
signiﬁcant (p < 0.05). There was no signiﬁcant
difference between G2Tk/05,G 2 Os/984 and
G2Mal/835 mice.
The Pearson Chi Square test showed the
number of infected mice was not signiﬁcantly
different between the G2Os/2332 and G2Os/984,
whereas the number of infected mice was sig-
niﬁcantly different within G2 H5N1 groups
(p = 0.07). Furthermore, the number of infected
mice within G2 H7N1 groups was not signiﬁ-
cantly different when compared to G2Tk/05
whereas the difference was signiﬁcant when
compare to G2Mal/835.
3.4. Sequence analysis
The completeORF of theoriginal strains and
of the post-infection isolates were sequenced.
Post-infection viruses were genetically similar
when compared to the respective challenge
viruses. Only a few silent mutations were
observed in isolates recovered p.i.
4. DISCUSSION
Although the efﬁciency of transmission is a
key factor in determining the severity of inﬂu-
enza epidemics, viral properties that affect the
transmissibility of inﬂuenza viruses among
Table V. Quantitative Real-Time PCR and viral isolation results of H5N1 contact mice (G2).
ID number Detail Organs
b qRRT-PCR Copies/lL Virus isolation
(A) G2Tk/05 contact mice
1 Dead (10th p.c) Brain + 5.5E + 09 +
Lung/trachea + 3.05E + 06 +
Spleen + 4.3E + 04 
Intestinal content + 2.7E + 05 
2 Dead (10th p.c.) Brain + 1.9E + 06 +
Lung/trachea + 2.7E + 05 +
3 Dead (12th p.c.) Brain NA
a NA NA
Lung/trachea + 2.2E + 05 
4 Dead (12th p.c.) Brain + 3.3E + 08 +
Lung/trachea + 6.4E + 05 +
Spleen + 2.2E + 05 
5 Sacriﬁced* (20th p.c.) Brain + 3.05E + 04 
Spleen + 5.96E + 04 
6 Sacriﬁced* (20th p.c.) Brain + 4.82E + 05 +
(B) G2Mal/835 contact mice
1 Sacriﬁced** (10th p.c.) Lung/trachea + 2.68E + 05 +
* Mice sacriﬁced for ethical reason (severe signs of disease).
** Animal sacriﬁced according to the experimental protocol.
a Not analyzed. Samples found putreﬁed could not be processed.
b From G2 mice brain, lung, spleen, liver, kidney and intestinal content were collected. This table shows the
number of mice and the type of tissues found positive when ﬁrst processed by qRRT-PCR.
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poorly understood.
Factors affecting pathogenicity and transmis-
sion of inﬂuenza viruses appear to be polygenic
[13, 21] and several mammalian models have
been used to investigate this topic, particularly
for human inﬂuenza viruses [1, 32, 33].
To our knowledge, this is the ﬁrst report of
direct transmission of HPAI viruses in BALB/
c mice.
Our data demonstrate that H7N1 and H5N1
HPAI viruses can transmit from infected mice
to contact sentinels. Mice infected with different
avian inﬂuenza virus strains exhibited signiﬁ-
cant differences in the patterns of infection
and transmission, indicating that this species
could be used to investigate viral factors inﬂu-
encing transmissibility.
In fact, differences in terms of morbidity and
transmissibility between H7N1 and H5N1
viruses emerged from this study. Severe clinical
signs and changes in body weight were
recorded with H7N1 viruses both in infected
and contact sentinels, whereas acute mortality
with no apparent signs of disease was recorded
in G1Tk/05 and G2Tk/05. The strain Mal/835
(LD50 >1 0
6) showed a non-lethal phenotype
in infected mice. Although H5N1 Mal/835 viral
replication was detected in different organs in
one mouse, the infected animal did not suc-
cumb to infection. This was observed also in
a previous study [29] using an HPAI H5N1
virus isolated from a human case in 2003
(HK/213). This virus replicated to high titre in
the lungs of inoculated mice as well as extra
pulmonary organs without lethal outcome
unless administered at high doses. In addition,
for Mal/835 there was no consistent evidence
of transmission to contact sentinels and no sero-
conversion was observed in surviving animals.
Based on virological and serological data, in
both H7N1 infected and sentinel groups, inap-
parent infections did not occur. All the infected
mice developed severe clinical signs and died
or were euthanized for ethical reasons. Few
infected or in-contact mice with both H5N1
viruses resulted infected at the time of sampling
but remained apparently healthy. In this experi-
ment it was not possible to assess whether these
mice would have developed the disease at a
later stage. However, the fact that surviving
mice at the end of the experiment did not show
seroconversion might suggest that undetectable
infections, if any, may occur in a small propor-
tion of mice exposed to HPAI H5N1.
H5N1 Tk/05, harbouring PB2 E627K,
showed a highly pathogenic phenotype in mice,
causing lethal infection and systemic replication
in both infected mice and contact sentinels. This
is consistent with extra-respiratory apparatus
detection of H5N1 HPAI in infected human
patients and with a recent study [6]s h o w i n g
that a single amino acid change at position
627 of PB2 gene may be sufﬁcient for strain
HK484 H5N1 to overwhelm the host defence
mechanisms that otherwise limit infection to
the respiratory tract.
However, data from the present study indi-
cate that the role of the two known major muta-
tions in the PB2 gene, i.e. E to K mutation in
position PB2 627 and D to N in PB2 701
[32], in pathogenicity and transmission of avian
inﬂuenza viruses in mammalian species appears
not to be totally deﬁned, supporting the fact that
other virus determinants could be involved.
Consistently with previous studies [21, 26,
29], viruses harbouring a PB2 E627K (Os/
2332 and Tk/05) replicated faster and were
more aggressive in mice, although signiﬁcant
differences in terms of morbidity and lethality
were revealed among viruses possessing this
mutation. On the contrary, no differences were
revealed between Tk/05, harbouring the
E627K mutation and Os/984, lacking this
mutation. Furthermore, differences in terms of
lethality and transmissibility were observed
between Os/984 and Mal/835, both lacking
PB2 E627K and D701N mutations.
Based on the results of our study, it can be
suggested that the role of single amino acid
change at position 627 of PB2 gene in over-
whelming the host defence mechanisms and
provoking extra-respiratory infections [6]m a y
be subtype or even strain speciﬁc.
The differences observed in the contact
groups (G2) reﬂected the differences in morbid-
ity and pathogenicity observed in the infected
groups (G1) with few exceptions. The number
of mice infected in the G2 groups with different
strains was certainly different even if not
Vet. Res. (2010) 41:66 M. Rigoni et al.
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Tk/05. Mal/835 was poorly transmissible to in-
contact mice, being detected only in one, appar-
ently healthy animal. The appearance of disease
and mortality also varied among the G2 groups,
reﬂecting the variations observed in the infected
(G1) groups.
According to previous studies [20, 26, 28],
both HPAI H5N1 and H7N1 viruses are
pneumo- and neuro-pathogenic in mice. Com-
pared to the lungs, signiﬁcantly higher virus
loads were detected in the brain of mice
infected with Os/2332, Os/984 and Tk/05 (data
not shown). However this difference was not
signiﬁcant in the sentinels, suggesting that the
higher concentration of virus in the brain might
be dose-dependant.
The data resulting from this experiment may
be a good starting point for further studies.
Reverse genetic studies could be performed to
better understand the molecular determinants of
different viral patterns of transmission in mice.
The authors believe that other inbred strains
of mice should be used in transmission studies
with avian inﬂuenza viruses, since inbred mice
vary in their reactions to inﬂuenza infection,
particularly with regard to inﬂammatory
response and disease severity [4, 35].
In addition to that, the use of mice could be
suggested as a model for pathogenesis and
transmission of other inﬂuenza viruses like
equine, canine and sea mammals strains target-
ing 2-3 linked SA receptors.
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